EXIM Reauthorization: A Plan for AI Export Packages

Bottom line

If you lead export finance for a US consortium with a package in the American AI Exports Program, plan as if the Export-Import Bank of the United States (EXIM) cannot sign new commitments from January 1, 2027. Congress can renew its authority, and renewal bills are pending. But the public documents I reviewed do not explain how designated packages would be handled during a lapse. So put the burden on your own timetable: close what can close in the fourth quarter, line up a candidate alternative lender for the rest, and ask the agencies in writing what a designation is worth on a lapse day. The December 31, 2026 date comes from the statute. The missing lapse plan is a finding about the documents I reviewed, not proof that none exists.

Who this is for

One reader: the finance lead at a US company or consortium that submitted, or plans to submit, a full-stack artificial intelligence (AI) export package to the Department of Commerce. Commerce announced the inaugural call for proposals on April 1, 2026, covering April 1 to June 30, 2026. If you have not yet submitted, check aiexports.gov for the current submission status, because the documents I reviewed describe only that initial call. You answer to a foreign buyer who wants to know who will lend, and when. This brief is not a forecast of whether Congress acts, and it is not legal advice.

The clock

The statute sets the date. In the 2024 edition of the US Code, 12 U.S.C. 635f says EXIM continues to exercise its functions “until the close of business on December 31, 2026”. The same section lets the bank acquire obligations before that date that mature later, so deals completed before the cutoff can run past it. The China and Transformational Exports Program (CTEP) has its own sunset. 12 U.S.C. 635(l)(3)(C) says the program “shall expire on December 31, 2026”, and the program’s covered areas include artificial intelligence. Traverse, a site that tracks US trade policy from official records, reported the same date on June 16, 2026. From today, October 8, 2026, that is 84 days. I read the 2024 edition of the Code, so check for later enactments before you rely on it.

The chairman has asked for a long renewal. On March 18, 2026 EXIM Chairman John Jovanovic testified to the House Financial Services Committee. EXIM’s release, dated March 19, quotes him asking Congress to reauthorize the Bank and CTEP “for ten years”. The same release cites “more than $71 billion in active transactions”, which is the chairman’s description of the pipeline, not an approved or disbursed amount. The US Chamber of Commerce, in a letter dated March 16, urges the same ten years.

Renewal bills exist, and they differ on length. S.3772, the Export-Import Bank Reauthorization Act of 2026, was introduced on February 4, 2026 by Senator Kevin Cramer with Senator Mark Warner. It replaces 2026 with 2036 in the Bank’s authority provision and in the CTEP sunset. Warner’s release is dated February 5. A House Financial Services Committee discussion draft, posted with the March 18 hearing materials, replaces 2026 with 2031, a five-year extension. It is an unnumbered draft, not an introduced House bill. S.4781, the Make More in America Act of 2026, was introduced on June 15, 2026 by Senator Charles Schumer, and Traverse discusses it as a marker for EXIM reauthorization. I did not review S.4781’s terms. The bill status files I retrieved from GovInfo on October 8 (S.3772, S.4781) list referral to the Senate Banking Committee as the latest action on both Senate bills. Neither has passed a chamber. Do not plan around any bill’s terms.

What a lapse has done before

EXIM’s historical timeline records that its charter and operating authority lapsed for five months in 2015, the longest gap in its history. In a letter to customers dated December 4, 2015, the chairman said the President had signed the reauthorization that day and that EXIM would resume authorized activities, with online systems expected to be fully operational by December 8. The same letter warned that transactions above $10 million still required board approval and had to wait for Senate confirmation of members to restore a quorum. The timeline records that the board lost its quorum on July 20, 2015 and regained one in May 2019.

The lesson is narrow. A lapse has happened before, EXIM expected to restart within days, and the effect on large transactions lasted well past the day the authority returned.

What the record says about your package

Commerce says designated packages “may receive one or more” listed benefits, one of which is “Facilitated access to federal financing tools and interagency coordination”. The aiexports.gov FAQ adds that financing referrals are “subject to each agency’s independent statutory authorities, underwriting standards, and Program requirements”. Neither document names EXIM, and neither says what happens to a package if EXIM’s authority lapses.

EXIM launched ExportAI on May 21, 2026, an initiative aimed at AI exports. Its release says EXIM is “unlocking potentially billions in financing” for US AI exports. It gives no firm dollar figure, so treat the amount as aspirational.

The Development Finance Corporation (DFC) is a candidate alternative lender. Its chief executive, Ben Black, said on June 25, 2026 that after its reauthorization DFC “now has 205 billion dollars of investment capacity” across debt, equity and insurance. He also said the number one request from partners has been for investment in AI data centers. These are the agency’s own statements. They do not show that any particular package is eligible for DFC support or has a committed DFC term sheet.

What I could not find

Three gaps matter for your planning. Each means “not found in the documents I reviewed on October 8, 2026”, not “does not exist”.

No lapse rule for designated packages. The Commerce and EXIM documents I reviewed do not say how a designated package is treated if EXIM cannot sign new commitments.

No AI-specific view of the default cap. Under 12 U.S.C. 635e(a)(3), if EXIM’s default rate is 2 percent or more for a quarter, the Bank may not exceed the loans, guarantees and insurance outstanding on the last day of that quarter until the rate falls below 2 percent. I found no estimate of how a few large data-center credits would move the portfolio default rate, so I offer none.

No allocation rule between EXIM and DFC. The documents I reviewed do not say when a designated package should go to DFC instead of waiting for EXIM.

What to watch

Each item has a trigger and the decision it should change. Dates are the last ones I could verify.

1. A committee markup of EXIM reauthorization. Trigger: a scheduled markup of S.3772, the House draft or a rival vehicle. Decision: if a markup is scheduled before the end of November, keep the plan to close in the fourth quarter and hold your fallback in reserve. If nothing is scheduled by December 1, make the fallback active. The December 1 date is my own planning threshold, not an official deadline. Why: Traverse says the likeliest path is amendments folded into the year-end reauthorization. That is one analyst’s assessment, not a fact.

2. Length of the renewal. Trigger: any text that sets a term shorter than the ten years requested. The House draft already runs five. Decision: a short renewal means another cliff soon. Do not assume EXIM will be available for new commitments after the renewal term. Existing authorized obligations can mature later, so confirm servicing and disbursement terms for your transaction.

3. Whether CTEP’s sunset is extended. Trigger: enacted text that amends 12 U.S.C. 635(l)(3)(C), or EXIM guidance on the program after December 31. Decision: CTEP’s expiry sits in its own statutory provision, and both bill texts amend it. A renewal of the bank’s general authority that leaves that provision unchanged would leave the program’s own December 31, 2026 expiry in place. If the enacted text does not extend CTEP, reprice your financing plan without it and ask EXIM directly how it will treat pending AI transactions.

4. Any Commerce or EXIM statement on designated packages after a lapse. Trigger: a notice, FAQ or letter that says how pending packages are handled. Decision: if one appears, adopt its terms in your buyer documents. If none appears by mid-December, tell your buyer in writing that financing timing after December 31 is not confirmed.

5. DFC signals on AI packages. Trigger: a DFC term sheet, pipeline notice or staff statement that treats an AI export package as in scope. Decision: if DFC confirms scope, open a parallel conversation now. DFC’s debt, equity and insurance tools may not match an export-credit loan, so test whether your buyer will accept a different structure.

Options for the finance lead

These are my own readings of the public record. I have no insider knowledge of how any agency is handling this.

Option 1: Write to the agencies this month. Ask Commerce and EXIM one question in writing: how will a designated package be treated if EXIM authority lapses on January 1? The cost is time. A written non-answer is still useful, because it tells your buyer and lenders what you cannot promise.

Option 2: Name a fallback lender for each package. DFC is the candidate. The gain is a parallel financing route if DFC confirms eligibility, completes underwriting and agrees terms. The cost is a structure change, because a buyer expecting an export-credit loan may not want equity or a different risk profile.

Option 3: Front-load what can close. Move the packages nearest signature into the fourth quarter. The gain is real deals in place of promises. The cost is pressure on due diligence, and it does nothing for packages that cannot close by December 31.

Combine Option 1 with either of the others. Option 1 costs least and sharpens the other two.

What this is not

This is not a prediction that Congress will fail. The record shows a chairman, a trade group and several bills all pointing toward renewal. It is not a read on any specific package. The gap it describes is a gap in the documents I reviewed, and the agencies may have guidance that has not been published.

Limits

This is a desk review of the public documents linked above, all opened on October 8, 2026. It does not draw on interviews or internal documents. The statutory text is the 2024 edition of the US Code, so later enactments need a fresh check before you act. Bill status comes from GovInfo status files retrieved that day, and the House text is a discussion draft whose status I could not establish beyond the hearing record. Traverse is a secondary source. A CSIS analysis of the same expiry date was not accessible for direct opening, so this brief does not rely on it. Congress may act at any time before the deadline, and anything here could be out of date within weeks.

Drafted with AI assistance and checked against the linked sources by the author.